Vivo Bio Tech Limited has submitted a regulatory compliance report to BSE Limited regarding the re-lodgement of transfer requests for physical shares, as mandated by SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026.
The report was prepared by the company's Registrar and Share Transfer Agent, Aarthi Consultants Private Limited, and covers the period ended September 2026.
Status Report Details
For the month of September 2026, the following statistics were reported:
- Number of requests received during the month: NIL
- Number of requests processed during the month: NIL
- Number of requests approved during the month: NIL
- Number of requests rejected during the month: NIL
- Average time taken for processing of requests: NA
The report confirms that no shareholder requests were received for re-lodgement of physical share transfer requests under the special window provided by the SEBI circular during the reporting period.
Financial Impact
No financial impact disclosed. The report is purely procedural and compliance-oriented.